API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
31
PharmaCompass offers a list of Toremifene Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Toremifene Citrate manufacturer or Toremifene Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Toremifene Citrate manufacturer or Toremifene Citrate supplier.
PharmaCompass also assists you with knowing the Toremifene Citrate API Price utilized in the formulation of products. Toremifene Citrate API Price is not always fixed or binding as the Toremifene Citrate Price is obtained through a variety of data sources. The Toremifene Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Toremifene Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Toremifene Citrate, including repackagers and relabelers. The FDA regulates Toremifene Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Toremifene Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Toremifene Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Toremifene Citrate supplier is an individual or a company that provides Toremifene Citrate active pharmaceutical ingredient (API) or Toremifene Citrate finished formulations upon request. The Toremifene Citrate suppliers may include Toremifene Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Toremifene Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Toremifene Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Toremifene Citrate active pharmaceutical ingredient (API) in detail. Different forms of Toremifene Citrate DMFs exist exist since differing nations have different regulations, such as Toremifene Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Toremifene Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Toremifene Citrate USDMF includes data on Toremifene Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Toremifene Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Toremifene Citrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Toremifene Citrate Drug Master File in Japan (Toremifene Citrate JDMF) empowers Toremifene Citrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Toremifene Citrate JDMF during the approval evaluation for pharmaceutical products. At the time of Toremifene Citrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Toremifene Citrate suppliers with JDMF on PharmaCompass.
A Toremifene Citrate written confirmation (Toremifene Citrate WC) is an official document issued by a regulatory agency to a Toremifene Citrate manufacturer, verifying that the manufacturing facility of a Toremifene Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Toremifene Citrate APIs or Toremifene Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Toremifene Citrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Toremifene Citrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Toremifene Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Toremifene Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Toremifene Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Toremifene Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Toremifene Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Toremifene Citrate suppliers with NDC on PharmaCompass.
Toremifene Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Toremifene Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Toremifene Citrate GMP manufacturer or Toremifene Citrate GMP API supplier for your needs.
A Toremifene Citrate CoA (Certificate of Analysis) is a formal document that attests to Toremifene Citrate's compliance with Toremifene Citrate specifications and serves as a tool for batch-level quality control.
Toremifene Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Toremifene Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Toremifene Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Toremifene Citrate EP), Toremifene Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Toremifene Citrate USP).